Prevention of autoimmune type 1 diabetes via mucosal tolerance: Is mucosal autoantigen administration as safe and effective as it should?

Scandinavian Journal of Immunology

Volumn 52, Issue 3, 2000, Pages 217-225

  Hanninen ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; COLLAGEN TYPE 2; INSULIN; MYELIN BASIC PROTEIN; OVALBUMIN; PEPTIDE DERIVATIVE;

AUTOIMMUNE DISEASE; CELL DESTRUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; DRUG SAFETY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MUCOSAL IMMUNITY; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; DESENSITIZATION, IMMUNOLOGIC; DIABETES MELLITUS, TYPE 1; DIGESTIVE SYSTEM; HUMANS; IMMUNE TOLERANCE; IMMUNIZATION; ISLETS OF LANGERHANS; LYMPHOID TISSUE; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; MUCOUS MEMBRANE; OVALBUMIN; RATS; SAFETY; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033849711     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00786.x     Document Type: Review

References (80)

1. Immune responses to dietary antigens: Oral tolerance
2. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases
3. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens
4. The pathogenesis of insulin-dependent diabetes mellitus
5. IA-2, A transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus
6. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited
7. Islet cell autoantigens in insulin-dependent diabetes
8. Insulin-dependent diabetes mellitus
9. Peripheral deletion of antigen-reactive T cells in oral tolerance
10. High dose oral tolerance in ovalbumin TCR-transgenic mice: Systemic neutralization of IL-12 augments TGF-β secretion and T cell apoptosis
11. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen
12. Passage of undergraded dietary antigen into the blood of healthy adults. Further characterization of the kinetics of uptake and the size distribution of the antigen
13. Passage of undegraded dietary antigen into the blood of healthy adults. Quantification, estimation of size distribution, and relation of uptake to levels of specific anti-bodies
14. In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice
15. + cells mediate active suppression
16. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: Suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells
17. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-β, and prostaglandin-E
18. Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway
19. Dendritic epidermal T cells inhibit T cell proliferation and may induce tolerance by cytotoxicity
20. Gamma delta T cells as mediators of mucosal tolerance: The autoimmune diabetes model
21. Mucosal tolerance is associated with, but independent of, up-regulation Th2 responses
22. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes
23. Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes
24. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin
25. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)
26. + T cells that suppress adoptive transfer of diabetes
27. Antigen-driven peripheral immune tolerance: Suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen
28. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
29. Inhibition of experimental auto-immune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: Synergistic effects of MBP 68-86 and 87-99
30. Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-A-treated Lewis rats: Future treatment of endogenous posterior uveoretinitis?
31. Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: Suppression of experimental autoimmune uveoretinitis is retinal antigen specific
32. The NOD mouse: A model for analyzing the interplay between heredity and environment in development of autoimmune disease
33. The murine autoimmune diabetes model: NOD and related strains
34. The NOD mouse model of type 1 diabetes: As good as it gets?
35. Immune responses to fed protein antigens in mice. 3. Systemic tolerance or priming is related to age at which antigen is first encountered
36. Dietary manipulation and induction of tolerance
37. Effects of brief early exposure to partially hydrolyzed and whole cow milk proteins
38. Development of immune response to cow's milk proteins in infants receiving cow's milk or hydrolyzed formula
39. Immune responses of mice to orally administered asialo GM1-specific rabbit IgG in the presence or absence of cholera toxin
40. Expression of a dietary protein in E. coli renders it strongly antigenic to gut lymphoid tissue
41. Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes
42. Cow milk feeding induces antibodies to insulin in children - A link between cow milk and insulin-dependent diabetes mellitus?
43. Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals
44. Induction by chronic autoimmune arthritis in DBA/1 mice by oral administration of type II collagen and Escherichia coli lipopolysaccharide
45. Oral insulin does not prevent insulin-dependent diabetes mellitus in BB rats
46. Potential risk of oral insulin with adjuvant for the prevention of Type I diabetes: A protocol effective in NOD mice may exacerbate disease in BB rats
47. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein
48. Complexities of applying nasal tolerance induction as a therapy for ongoing relapsing experimental autoimmune encephalomyelitis (EAE) in DA rats
49. Induction of autoimmune diabetes by oral administration of autoantigen
50. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells
51. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes
52. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent
53. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice
54. + T cells or interferon (1FN)-γ in a murine model of allergen sensitization
55. Regulation of IgE responses to inhaled antigen in mice by antigen-specific γδ T cells
56. + suppressor T cells
57. CD4+ but not CD8+ T cells are required for the induction of oral tolerance
58. Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization
59. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo
60. Nasal immunization with group B streptococci can induce high levels of specific IgA antibodies in cervicovaginal secretions of mice
61. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses
62. Nasal-associated lymphoid tissue: Phenotypic and functional evidence for the primary role of peripheral node addressin in naive lymphocyte adhesion to high endothelial venules in a mucosal site
63. Mucosa-associated (β7-integrin(high)) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior
64. Recirculation and homing of lymphocyte subsets: Dual homing specificity of beta 7-integrin (high)-lymphocytes in nonobese diabetic mice
65. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library
66. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
67. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
68. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
69. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
70. Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions
71. T and B cell tolerance and responses to viral antigens in transgenic mice: Implications for the pathogenesis of autoimmune versus immunopathological disease
72. T cells causing immunological disease
73. Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens
74. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation
75. Functions of newly identified members of the tumor necrosis factor receptor/ligand superfamilies in lymphocytes
76. T cell co-stimulatory molecules other than CD28
77. Mucosal tolerance: A two-edged sword to prevent and treat autoimmune diseases
78. Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance
79. Regulation of antigen-specific IgE, IgGl, and mast cell responses to ingested allergen by mucosal tolerance induction